Search Results - "Takeuchi, Hiroyoshi"

Development and validation of the Japanese version of the Sport Engagement Scale.

Authors: HIOKI, KAZUKI HOTTA, SHION KURAMOCHI, SHIN et al.

Source: Journal of Physical Education & Sport. Feb2026, Vol. 26 Issue 2, p223-233.

Response to the letter to the Editor from Araujo and colleagues on the research article entitled, "Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment‐resistant schizophrenia receiving clozapine: A 1‐year retrospective cohort study"

Authors: Tsukahara, Masaru So, Ryuhei Yoshimura, Yusaku et al.

Source: Acta Psychiatrica Scandinavica. May2024, Vol. 149 Issue 5, p436-438. 3p.

Subjects: Smoking, Valproic acid, Disease relapse, Tobacco, Clozapine, People with schizophrenia

Impact of clozapine once-daily versus multiple-daily dosing regimen on relapse in patients with treatment-resistant schizophrenia: A 1-year retrospective cohort study.

Authors: Tsukahara, Masaru So, Ryuhei Kitagawa, Kohei et al.

Source: Psychopharmacology. Jan2025, Vol. 242 Issue 1, p161-171.

Mortality in patients with schizophrenia in Japan.

Authors: Nomura, Nobuyuki Misawa, Fuminari Fujii, Yasuo et al.

Source: Social Psychiatry & Psychiatric Epidemiology. Oct2024, Vol. 59 Issue 10, p1785-1792. 8p.

Subjects: Mortality risk factors, Logistic regression analysis, People with schizophrenia, Disease risk factors, Schizoaffective disorders

Geographic Terms: Japan

Placebo versus no treatment for people with schizophrenia: A systematic review and meta‐analysis.

Authors: Nomura, Nobuyuki Shimomura, Yutaro Kikuchi, Yuhei et al.

Source: Psychiatry & Clinical Neurosciences Reports. Dec2025, Vol. 4 Issue 4, p1-3. 3p.

Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment‐resistant schizophrenia receiving clozapine: A 1‐year retrospective cohort study.

Authors: Tsukahara, Masaru So, Ryuhei Yoshimura, Yusaku et al.

Source: Acta Psychiatrica Scandinavica. Nov2023, Vol. 148 Issue 5, p437-446. 10p.

Subjects: Smoking, Valproic acid, Disease relapse, Clozapine, People with schizophrenia

Geographic Terms: Japan

Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis.

Authors: Kuzo, Nazar Haen, Ekkehard Ho, Dominic M. et al.

Source: European Archives of Psychiatry & Clinical Neuroscience. Oct2023, Vol. 273 Issue 7, p1567-1578. 12p. 2 Charts, 2 Graphs.

Subjects: Universität Regensburg, Clozapine, Patient compliance, Cross-sectional method, Patient preferences, Neuroleptic malignant syndrome, Odds ratio, Agranulocytosis

Geographic Terms: Switzerland

Clozapine-associated pneumonia: a gut–lung–brain axis perspective.

Authors: Cai, Yi Nakamura, Hiroyuki Takeuchi, Hiroyoshi et al.

Source: European Archives of Psychiatry & Clinical Neuroscience. Jun2026, p1-3. 3p.

Survey of benzodiazepine and antidepressant use in outpatients with mood disorders in Japan.

Authors: Uchida, Hiroyuki Suzuki, Takefumi Mamo, David C. et al.

Source: Psychiatry & Clinical Neurosciences. Apr2009, Vol. 63 Issue 2, p244-246. 3p. 1 Chart.

Subjects: Therapeutics, Benzodiazepines, Antidepressants, Affective disorders, Medical research

Geographic Terms: Japan

Restarting smoking after discharge from clozapine inpatient initiation: Elevated rehospitalization rates smoking & clozapine rehospitalization.

Authors: So, Ryuhei Tsukahara, Masaru Nakajima, Shinichiro et al.

Source: Psychiatry & Clinical Neurosciences. Apr2024, Vol. 78 Issue 4, p259-260. 2p.

Subjects: Clozapine, Patient readmissions, Smoking statistics

Does short‐term antipsychotic discontinuation of up to 3 weeks worsen symptoms in acute schizophrenia? A pooled analysis of placebo washout data.

Authors: Takeuchi, Hiroyoshi Watabe, Kei

Source: Psychiatry & Clinical Neurosciences. Jun2023, Vol. 77 Issue 6, p338-344. 7p. 5 Charts.

Subjects: Schizophrenia, Placebos, Disease exacerbation, Antipsychotic agents, Symptoms, Neuroleptic malignant syndrome

Association of protein distribution and gene expression revealed by positron emission tomography and postmortem gene expression in the dopaminergic system of the human brain.

Authors: Yamamoto, Yasuharu Takahata, Keisuke Kubota, Manabu et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Nov2023, Vol. 50 Issue 13, p3928-3936. 9p.

Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first‐episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms.

Authors: Takeuchi, Hiroyoshi Takekita, Yoshiteru Hori, Hikaru et al.

Source: Human Psychopharmacology: Clinical & Experimental. Nov2021, Vol. 36 Issue 6, p1-9. 9p.

Subjects: Drug therapy, Aripiprazole, Neuropsychopharmacology, Patient compliance, Patient preferences, Schizophrenia

Effectiveness of brexpiprazole in the treatment in a patient with Huntington's disease.

Authors: Mimura, Yu Funayama, Michitaka Oi, Hiroki et al.

Source: Psychiatry & Clinical Neurosciences. Apr2020, Vol. 74 Issue 4, p278-279. 2p.

Subjects: Huntington disease, Treatment effectiveness, Chorea

Predictors of response to pharmacotherapy in children and adolescents with psychiatric disorders: A combined post hoc analysis of four clinical trial data.

Authors: Tsujii, Takashi Sakurai, Hitoshi Takeuchi, Hiroyoshi et al.

Source: Neuropsychopharmacology Reports. Dec2022, Vol. 42 Issue 4, p516-520. 5p.

Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia.

Authors: Aoki, Yumi Takaesu, Yoshikazu Matsui, Kentaro et al.

Source: Neuropsychopharmacology Reports. Sep2023, Vol. 43 Issue 3, p391-402. 12p.

Effectiveness of mindfulness-based interventions for people with dementia and mild cognitive impairment: A meta-analysis and implications for future research.

Authors: Nagaoka, Maki Hashimoto, Zenta Takeuchi, Hiroyoshi et al.

Source: PLoS ONE. 8/2/2021, Vol. 16 Issue 8, p1-16. 16p.

Changes in metabolic parameters following a switch to aripiprazole in Japanese patients with schizophrenia: One-year follow-up study.

Authors: Takeuchi, Hiroyoshi Uchida, Hiroyuki Suzuki, Takefumi et al.

Source: Psychiatry & Clinical Neurosciences. Feb2010, Vol. 64 Issue 1, p104-106. 3p. 1 Chart.

Subjects: Patients, Schizophrenia, Triglycerides, Prolactin genes, Therapeutics

Geographic Terms: Japan

A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorder.

Authors: Takeuchi, Hiroyoshi Remington, Gary

Source: Psychopharmacology. Jul2013, Vol. 228 Issue 2, p175-185.

How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?—A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.

Authors: Suzuki, Takefumi Uchida, Hiroyuki Watanabe, Koichiro et al.

Source: Psychopharmacology. Dec2007, Vol. 195 Issue 2, p285-295.